bronchiectasis
BRONCHIECTASIS
Bronchiectasis is an irreversible pathologic dilatation or ectasia of the bronchi due to repeated airway infection and inflammation.
It enhances susceptibility to bronchial infection and increases inflammatory reaction which causes further lung damage.
Classic symptoms of of bronchiectasis are cough with chronic sputum production along with recurring infective exacerbations and hemoptysis.

Supportive Therapy

Specific Therapy for Individual Causes
Hypogammaglobulinemia
  • Administer IV immunoglobulins w/ guidance & supervision from an immunologist
Primary Ciliary Dyskinesia
  • More intensive therapy based on the assumption that disease progression is more likely
  • Emphasis on physical therapy
TB, HIV, Rheumatoid arthritis, Sarcoidosis
  • Treat active associated disease
  • Bronchiectasis may precede, accompany or follow the development of associated disease
Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Control of asthma & prevention of damage from acute exacerbations of ABPA
  • Consider maintenance oral corticosteroids
  • Antifungal therapy remains 2nd-line choice, unless there is associated invasive Aspergillosis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 25 Oct 2016

Nivolumab did not meet the primary endpoint of superior progression-free survival (PFS) vs platinum-based chemotherapy in the phase III Checkmate026 trial in patients with stage IV recurrent, PD-L1–positive non-small-cell lung carcinoma (NSCLC), according to results reported recently at the European Society of Medical Oncology (ESMO) Congress 2016. 

Pearl Toh, 24 Nov 2016
New treatments such as pirfenidone and nintedanib slow lung function decline and progression of idiopathic pulmonary fibrosis (IPF), although response to treatment can vary dramatically among patients, according to a presentation at the 21st Congress of the Asian Pacific Society of Respirology (APSR 2016) held in Bangkok, Thailand.
16 Oct 2016
Irritable bowel syndrome and asthma share a bidirectional association, a new study reports. Further, atopy potentially plays a role in the underlying mechanisms of this association.
Audrey Abella, 09 May 2018
The potent and highly selective RET* inhibitor BLU-667 was well-tolerated and exhibited promising clinical activity among patients with advanced, RET-altered solid cancers that progressed despite multikinase inhibitor therapy, according to data presented at AACR 2018.